Acceso abierto

Concentration of circulating tumour DNA in patients with metastatic gastric cancer and its prognostic significance

E. Karamitrousis

E. Karamitrousis

University Medical Oncology Department, Medical School, Democritus University of ThraceAlexandroupolis, Greece
Buscar este autor en
Sciendo|Google Scholar
Karamitrousis, E.
, 
I. Balgkouranidou

I. Balgkouranidou

University Medical Oncology Department, Medical School, Democritus University of ThraceAlexandroupolis, Greece
Buscar este autor en
Sciendo|Google Scholar
Balgkouranidou, I.
, 
N. Xenidis

N. Xenidis

University Medical Oncology Department, Medical School, Democritus University of ThraceAlexandroupolis, Greece
Buscar este autor en
Sciendo|Google Scholar
Xenidis, N.
, 
K. Amarantidis

K. Amarantidis

University Medical Oncology Department, Medical School, Democritus University of ThraceAlexandroupolis, Greece
Buscar este autor en
Sciendo|Google Scholar
Amarantidis, K.
, 
E. Biziota

E. Biziota

University Medical Oncology Department, Medical School, Democritus University of ThraceAlexandroupolis, Greece
Buscar este autor en
Sciendo|Google Scholar
Biziota, E.
, 
T. Koukaki

T. Koukaki

University Medical Oncology Department, Medical School, Democritus University of ThraceAlexandroupolis, Greece
Buscar este autor en
Sciendo|Google Scholar
Koukaki, T.
 y 
S. Kakolyris

S. Kakolyris

University Medical Oncology Department, Medical School, Democritus University of ThraceAlexandroupolis, Greece
Buscar este autor en
Sciendo|Google Scholar
Kakolyris, S.
  
07 may 2022
Concentration of circulating tumour DNA in patients with metastatic gastric cancer and its prognostic significance's Cover Image
Acerca de este artículo
Artículo anterior
Artículo siguiente
Cite
Descargar portada
Categoría del artículo: Research Article
Publicado en línea: 07 may 2022
Páginas: 72 - 76
Recibido: 14 oct 2021
Aceptado: 23 dic 2021
DOI: https://doi.org/10.2478/fco-2021-0010
Palabras clave
© 2021 Karamitrousis E. et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Gastric cancer is one of the most common cancers worldwide. The amount of cell-free DNA (cfDNA) in the blood of patients with gastric cancer was found to be higher than that of healthy controls (69.1 ng/μL vs. 34.8 ng/μL). Patients with cfDNA ≤ 50 ng/μL were found to have an increased overall survival (OS) and progression free survival (PFS) than in patients with cfDNA > 50 ng/μL.

Idioma:
Inglés
Calendario de la edición:
2 veces al año
Temas de la revista:
Medicina, Medicina Clínica, Medicina Interna, Hematología, oncología
RSS Feed de revista